Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04453202
Recruitment Status : Completed
First Posted : July 1, 2020
Last Update Posted : September 28, 2021
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 24, 2020
Actual Study Completion Date : April 9, 2021
Certification/Extension First Submitted : September 23, 2021